Well said,
in addition for some tumours, identifying an antigen that is only expressed on the tumour cell and not on healthy tissue is a significant obstacle
to be overcome. Jeffrey Molldrem seems to specialise in this area.
PTX + MD Anderson collaboration means multiple opportunities that the PTX platform will be used as the treatment platform used to treat many, many different cancers.
Ann: PTX strategic collaboration with MD Anderson Cancer Center, page-30
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.85M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.7¢ | $10.75K | 227.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 246129 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 1909 | 1 |
View Market Depth
| Last trade - 10.12am 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.6¢ |
Change
0.000 ( 2.13 %) |
||||
| Open | High | Low | Volume | ||
| 4.7¢ | 4.7¢ | 4.6¢ | 56927 | ||
| Last updated 10.21am 21/05/2024 ? | |||||
| PTX (ASX) Chart |